Skip to content

Ananda Developments - Ananda Launches New Interactive Investor Hub


Announcement provided by

Ananda Pharma Plc · ANA

14/12/2023 07:00

Ananda Developments - Ananda Launches New Interactive Investor Hub
RNS Number : 6859W
Ananda Developments PLC
14 December 2023
 

 

Reach - Non-Regulatory

 

Ananda Developments plc

 ("Ananda" or the "Company")

 

Ananda Developments Launches New Interactive Investor Hub, investors.anandadevelopments.com to provide stakeholders with a more proactive method of communication and enquiry support

 

Ananda Developments Plc ('Ananda') a company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions is pleased to announce the launch of Ananda's Interactive Investor Hub. For both existing and prospective stakeholders it brings all Ananda's content into a single integrated platform to better inform and engage with investors and stakeholders, including:

 

●     regulatory announcements

●     annual and interim reports

●     corporate presentations

●     educational material

●     Interviews with the company's directors

●     corporate research on Ananda Developments

 

Investor Hub also provides an interactive online experience allowing the Company's stakeholders to comment on and ask the Ananda team questions via a portal which will be monitored and responded to promptly. Company RNSs will also still be released via the current regulated services.

 

To sign up for the Ananda Investor Hub:

 

1.    Visit investors.anandadevelopments.com

2.    Follow the prompts to sign up for an investor hub account

3.    Complete your account profile

 

Ananda's CEO, Melissa Sturgess commented: "We have always encouraged our stakeholders to engage with us. We see Investor Hub as an effective platform upon which to further enable our stakeholders including shareholders, potential shareholders and interested parties to interact with Ananda. Investor Hub will also allow us to share more video material, information and insights about our activities and plans. We encourage our shareholders, potential shareholders and wider stakeholders to trial Investor Hub and provide feedback."

 

To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are:  

  

·              Investor Hub: investors.anandadevelopments.com

·              Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=   

·              LinkedIn: https://www.linkedin.com/company/anadevelopments/   

·              Twitter: https://twitter.com/AnandaPlc

·              Investor Meet Company: https://www.investormeetcompany.com/ananda-developments-plc/register-investor

-Ends-

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

For more information please contact:

InvestorHub

Engage with us directly at Ananda Developments Investor Hub

Sign up at investors.anandadevelopments.com

ANANDA DEVELOPMENTS PLC

Chief Executive Officer

Melissa Sturgess


Executive Director

Jeremy Sturgess-Smith

+44 (0)7463 686 497 ir@anandadevelopments.com

SP ANGEL CORPORATE FINANCE LLP

+44 (0)20 3470 0470

Corporate Finance

Richard Morrison

Harry Davies-Ball

 

Corporate Broking

Abigail Wayne

Rob Rees


 

About Ananda Developments

Ananda is an AQSE-listed company whose ambition is to be a leading provider of cannabinoid-based

medicines for the treatment of complex, chronic inflammatory pain conditions.

 

For further information on the Company visit https://anandadevelopments.com/ or sign up at www.investors.anandadevelopments.com.

https://investors.anandadevelopments.com/link/lya2je

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFFUFLDEDSELE]]>

View more ...

ANA announcementsAll announcements

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers
ISO 27001 Certified

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal